
|Articles|August 13, 2015
GSK: Legionnaires Disease Bacteria Causes Temporary Closedown of US Site
August 13, 2015.
Advertisement
The
GSK said the bacteria had been isolated after routine testing and that it is “working to rectify and restore operations as soon as possible”.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
Agentic AI and the Future of Commercial Excellence in Life Sciences
3
FDA Expands Approval for Arexvy for Adult Patients Aged 18-49
4
Americans Cutback on Expenses to Cover Healthcare Costs: Report
5




